ATYR
aTyr Pharma
ATYR
ATYR
33 hedge funds and large institutions have $12.1M invested in aTyr Pharma in 2018 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
76% less capital invested
Capital invested by funds: $51.3M → $12.1M (-$39.2M)
Holders
33
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$133K | |
| 2 | +$95K | |
| 3 | +$35K | |
| 4 |
ARTA
A.R.T. Advisors
New York
|
+$30K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$21.9K |
Top Sellers
| 1 | -$10.6M | |
| 2 | -$4.95M | |
| 3 | -$303K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$290K |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$117K |